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Abstract.  When cells from normal  human epidermis 
and from the human  squamous cell carcinoma line 
SCC-13  were seeded on floating rafts of collagen and 
fibroblasts, they stratified and underwent terminal 
differentiation.  Although the program of differentiation 
in  SCC-13 cells was morphologically abnormal,  the 
cultures resembled normal epidermal  raft cultures by 
expressing the terminal  differentiation-specific keratins, 
K1/K10, and by restricting  their proliferative capacity 
to the basal-like cells of the population.  In addition, 
the differentiating cells of both normal and  SCC-13 
raft cultures expressed keratins K6 and K16, which are 
not normally expressed in epidermis,  but are synthe- 
sized suprabasally during  wound-healing and  in vari- 
ous epidermal diseases associated with hyperprolifera- 
tion.  While the behavior of normal and SCC-13 rafts 
was quite similar when they were cultured over normal 
medium,  significant biochemical differences began to 
emerge when the cultures were exposed to retinoic 
acid.  Most notably, while the SCC-13 cultures  still 
stratified extensively, they showed a marked inhibition 
of both abnormal  (K6/K16) and normal  (K1/K10) 
differentiation-associated keratins,  concomitantly with 
an overall disappearance of differentiated phenotype. 
Surprisingly,  the reduction in K6/K16 in retinoid- 
treated SCC-13 cultures was not accompanied by a de- 
crease in cell proliferation.  Using immunohistochemis- 
try combined with [3H]thymidine labeling,  we demon- 
strate that while the expression of K6 and K16 are 
often associated with hyperproliferation,  these keratins 
are only produced in the nondividing,  differentiating 
populations of proliferating cultures.  Moreover, since 
their expression can be suppressed without a corre- 
sponding decrease in proliferation,  the expression of 
these keratins cannot be essential to the nature of the 
hyperproliferative epidermal cell. 
T 
HE normal epidermis consists  of 10-20 layers whose 
cells possess distinct  structure  and  properties.  Only 
cells in the basal layer proliferate  (Weinstein and Van 
Scott,  1965). As cells leave this layer and begin to migrate 
towards the skin surface, they cease to divide and start to ter- 
minally  differentiate.  The cells enter the spinous  layer and 
increase steadily in size as they continue to be metabolically 
active  (Yardley and  Goldstein,  1976). During  this  phase, 
much of the cell's translational  machinery is devoted to mak- 
ing keratins, the major product of the differentiated epidermis 
(Matoltsy,  1975). These proteins  assemble into  8-nm  fila- 
ments that increase in number and aggregate into bundles in 
the cytoplasm of the differentiating  cell (Brody,  1960).  As 
cells reach the granular  layer, they enter a destructive phase 
and begin to lose their organelles,  leaving keratin  filaments 
as virtually the sole cytoplasmic  survivors of the differentia- 
tive process (Lavker and Matoltsy, 1970). Released from the 
skin surface, the dead squames are continually  being replen- 
ished by differentiating  cells migrating  outward. 
A number of changes in protein synthesis take place during 
terminal  differentiation.  The major change  is the induction 
of unusually  large keratins (Fuchs and Green, 1980), which 
occurs as a cell leaves the basal layer (Viac et al.,  1980). 
While basal cells express keratins  K5 (58 kD) and KI4 (50 
kD) (Nelson and Sun,  1983), suprabasal  cells express kera- 
tins K1 (67 kD), K2 (65 kD), K10 (56.5 kD), and Kll (56 
kD) (Fuchs and Green, 1980; Eichner et al., 1984). With the 
possible exception of K2 and Kll, which may be proteolytic 
degradation products of K1 and K10, respectively (Fuchs and 
Green,  1980; Tyner and Fuchs,  1986),  the shift to the ex- 
pression of these large keratins is due to changes in specific 
keratin  mRNAs (Fuchs and Green,  1980). The appearance 
of large keratin mRNAs is one of the earliest biochemical in- 
dications that a cell has  undergone  a commitment towards 
terminal  differentiation. 
In a number of epidermal diseases associated with hyper- 
proliferation,  the expression of these large keratins is down- 
regulated and a new set of keratins,  K6 (56 kD) and K16 (48 
kD), is induced (Weiss et al.,  1984; McGuire et al.,  1984). 
Similar to the large keratins,  K6 and KI6 are also located in 
the suprabasal  epidermal cells (Stoler et al.,  1988). Coinci- 
dently,  [3H]thymidine labeling of hyperproliferative  epider- 
©  The Rockefeller  University  Press,  0021-9525/89/07/295/13  $2.00 
The Journal of Cell Biology,  Volume  109, July  1989 295-307  295 mis such as psoriatic tissue has shown that the number of 
ceils synthesizing DNA is greatly enhanced in the suprabasal 
layers (Van Scott and Ekel, 1963; Weinstein and Van Scott, 
1965;  Penneys et al.,  1970;  Leigh et al.,  1985).  However, 
even though a  correlation between hyperproliferation and 
K6/K16 expression is well-documented, the extent to which 
the expression of these keratins plays a functional role in the 
process of epidermal cell proliferation remains to be deter- 
mined. 
The focus of the present study was to examine the relation 
between K6/KI6 expression and epidermal proliferation. We 
used as model systems normal and malignant human epider- 
mal cells cultured in vitro under conditions where they strati- 
fy and differentiate. Previously, we showed that when normal 
human epidermal cells or cells from the epidermal squamous 
cell carcinoma line SCC-13  are seeded on floating rafts of 
collagen and fibroblasts, they express both sets of suprabasal 
keratins in addition to the basal keratins (Kopan et al., 1987; 
Stoler et al., 1988). Hence, the biochemical processes which 
occur in vivo in response to epidermal proliferation also take 
place in vitro when this culture system is used. 
We chose to examine both normal and SCC-13 ceils, since 
the two cell types have different proliferative potentials (Wu 
and Rheinwald,  1981; Albers  and Taichman, unpublished 
results). However, we also wanted a method which would en- 
able us to manipulate both the process of differentiation and 
also the proliferative potential within an individual cell type. 
With respect to suppressing terminal differentiation, the task 
was relatively simple, since we knew that when retinoic acid 
is added to the medium underlying floating rafts of normal 
epidermal cultures, the expression of the terminal differenti- 
ation-specific keratins, KI and K10, is suppressed (Kopan et 
al., 1987). While K6 and KI6 are still synthesized in normal 
epidermal cultures, their expression also appeared to be re- 
duced somewhat in the presence of retinoids (see two-dimen- 
sional gels in Kopan et al., 1987).  Although we had not yet 
examined the effects of retinoic acid on raft cultures of SCC- 
13  cells, we had shown previously that when similar cell 
lines SCC-12  and SCC-15  (Wu and Rheinwald, 1981) were 
cultured on plastic in medium containing retinoic acid, they 
seemed to be even more sensitive to retinoids than normal 
keratinocytes (Kim et al., 1984). Hence, we anticipated that 
the SCC-13  raft cultures would be  responsive to retinoic 
acid. 
The  question  of whether  retinoids  inhibit or  stimulate 
epidermal proliferation has been a  matter of considerable 
controversy (Yuspa and Harris, 1974; Chopra and Flaxman, 
1975;  Hardy et  al.,  1975; Marcelo  and  Madison,  1984; 
Hashimoto et al.,  1985;  Connor, 1986;  Redfern and Todd, 
1988). However, preliminary studies examining relative rates 
at which normal human keratinocytes reach confluence when 
cultured on plastic in the presence of varying concentrations 
of retinoids have suggested a possible basis for the contro- 
versy: low levels of retinoids seemed to stimulate prolifera- 
tion, whereas higher levels seemed to be inhibitory (Fuchs 
and Green, 1981). Thus, by using retinoids to alter the prolif 
eration of normal and transformed human epidermal ker- 
atinocytes in vitro, we hoped to gain some insight as to the 
role of K6/K16 expression in hyperproliferative tissues. 
Specifically, the questions that we addressed in this study 
are: (a) How does the level of DNA synthesis differ in normal 
epidermal raft cultures and SCC-13 raft cultures? (b) Which 
cells of the stratified population of epidermal and SCC-13 
cultures are synthesizing DNA? (c)  Do DNA-synthesizing 
cells of the raft cultures express K6/K16? (d) Does retinoic 
acid influence the expression of K6/K16 in the raft cultures? 
(e) Does retinoic acid influence the level of DNA synthesis 
in raft cultures? (f) Can K6/K16 expression and epidermal 
ceil proliferation be uncoupled? (g) What are the mechanisms 
underlying the control of K6/KI6 expression in culture? 
Materials and Methods 
Preparation of Floating Epidermal Colonies on 
Fibroblast/Collagen Lattices 
The procedure for making and seeding collagen lattices was essentially as 
that described by Asselineau et al. (1985).  Type I collagen was combined 
with culture medium at 4°C as described by the manufacturer (Seikagaku 
America,  Inc.,  St.  Petersburg,  FL).  Mouse 3"I"3 fibrob|asts (Rheinwald 
and Green,  1975) were added to this solution at a concentration of 1.5  × 
105/ml,  and the mixture was pipetted  into 35-mm culture dishes (2  ml/ 
dish). To gel, lattices were placed in the incubator at 37°C.  After 2-3 h, 
medium was added at 2 ml/dish, and lattices were maintained in the incu- 
bator until ready for use (usually 12-72 h  after gellation). Cultures were 
fed with a  3:1  mixture of DME and Ham's F12  medium, supplemented 
with hydrocortisone (0.4  t~g/ml)  and  10%  FCS  (HyClone  Laboratories, 
Logan, UT). 
To prepare epidermal cultures, each dermal lattice was seeded with 3  × 
105 human SCC-13 keratinocytes (Rheinwald and Beckett, 1981) or normal 
epidermal  cells  (derived  from  foreskin and  kept  as  3-d  passage-cloned 
stocks under  liquid  nitrogen;  Rheinwald  and  Green,  1975;  Rheinwald, 
1980).  Cells were grown submerged in culture medium for 7  d.  At this 
point, lattices were removed from the dishes and placed on stainless steel 
grids (Asselineau et al., 1985,1986; Kopan et al., 1987). Grids were floated 
on medium for  10 d  before harvesting. Where indicated in the text,  1  x 
10  -7 to  I  x  10  -6 M  retinoic acid (Sigma Chemical Co., St.  Louis, MO) 
was added to this medium at the time the cultures were raised to the air- 
liquid  interface.  Retinoic acid was stored at  -70°C  in the dark as 400x 
stocks in dimethyl sulfoxide, and diluted into medium at each feeding. Con- 
trol plates with no retinoic acid still received a  1:400 dilution of dimethyl 
sulfoxide into the medium. 
pH]Thymidine Labeling of Cell Cultures 
Cells were cultured on rafts for  l0 d before labeling. 2  h before fixation, 
submerged rafts (controls) or floating rafts (experiment) were labeled with 
2  #Ci/ml  of [3H]thymidine  (89  Ci/mmol;  Amersham Corp.,  Arlington 
Heights, IL) were added to the medium. After returning cultures to the incu- 
bator for 2 h, raft cultures were thoroughly washed in PBS, and then fixed 
in Carnoy's solution for 30 min. Fixed cultures were embedded in paraffin 
and sectioned (5 /xm). 
Autoradiography and Hematoxylin/Eosin Staining 
of Raft Cultures 
Sections of fixed tissues were adhered to glass slides, and slides were dipped 
in xylenc to deparaffinize the sections. After two changes of 100%  xylene 
and one of 100%  ethanol (10 min each), slides were air-dried.  From this 
point until after developing, slides were kept in complete darkness. Slides 
were first dipped in NTB2 Kodak emulsion as described by the manufac- 
turer.  Dipped slides were air-dried for 90 min, and then stored at 4°C in 
a light-proof and radiation-proof lead bag for 3 wk before developing. The 
developing was done in  1/2×  Dektol (Kodak) at  14°C for 4  min (the de- 
veloper  should  be  diluted  with  glass distilled  water).  Developing  was 
stopped by dipping slides in 0.01 M  glacial acetic acid and fixed in Kodak 
GBX fixer for 4 min at 14°C. Slides were washed in cold running tap water 
for 15 min before staining with filtered 100% hematoxylin (Sigma Chemical 
Co.).  After ethanol dehydration, slides were stained with 0.05% eosin (in 
70% ethanol, 0.5% glacial acetic acid), washed in 100% ethanol, immersed 
in  xylene,  and  mounted under glass cover slips  with  Pro-Texx (Lerner 
Laboratories,  Pittsburgh, PAL 
Immunohistochemistry 
Fixed, paraffin-embedded sections (5 /.tm) were hydrated before staining. 
Sections were treated for 30 min at room temperature with a solution of 2% 
The Journal of Cell Biology, Volume  109,  1989  296 Figure l. Comparison of morphology and cell proliferation in normal and SCC-13 raft cultures. Human epidermal keratinocytes from nor- 
mal foreskin and from the squamous cell carcinoma line SCC-13  were cultured on collagen/fibroblast lattices as described in Materials 
and Methods. Unless otherwise indicated (see below), rafts were floated at the air-liquid interface. 2 h before harvesting, cultures were 
treated with [3H]thymidine as indicated in Materials and Methods. After radiolabeling, rafts were fixed for 30 min in Carnoy's solution, 
embedded in paraffin, and sectioned (5 ~m). Sections were subjected to autoradiography, followed by staining with hematoxylin and eosin. 
A and C, normal epidermal cultures; B, normal epidermal culture submerged in medium; D,  SCC-13  culture. Thin arrows in A denote 
radiolabeling of basal cell nuclei. Thick arrow in the inset of A denotes an unlabeled mitotic cell. Note that the basal-preferred labeling 
pattern is seen in both floating and submerged cultures (A and B, respectively). Dotted line in B denotes demarcation between basal epider- 
mal layer and artificial dermis. Low magnification photographs (C and D) illustrate the lower proliferation rate in normal versus SCC-13 
cultures, respectively. Bar: (A and B) 30 #m;  (C and D) 74/~m. 
BSA in PBS (BSA-PBS).  The solution was then replaced with fresh BSA- 
PBS containing a  1:100 dilution of monospecific rabbit polyclonal antisera 
against (a) a synthetic 7-mer coding for the carboxy terminus of human K6a 
(anti-K6; antiserum No. 415; Stoler et al., 1989),  or (b) a synthetic 15-mer 
coding for the carboxy terminus of  human K14 at a 1:200 dilution (anti-K14; 
antiserum No. 199; Stoler et al., 1988).  After a l-h incubation at room tem- 
perature, sections were washed 3×  in PBS (10 rain each) and then treated 
with a gold-conjugated goat anti-rabbit antiserum (15-nm gold particles; 
Janssen Life Science Products, Piscataway,  NJ). After an overnight incuba- 
tion at room temperature, sections were washed 6x  in PBS (10 min each), 
fixed for 15 min in PBS containing 2% glutaraldehyde, and washed 3x  in 
PBS (10 min each) followed by 3×  in glass distilled water (10 min each). 
Sections were then placed in a single glass jar, along with negative control 
sections in which the primary antiserum was omitted, and positive control 
sections from skin tissues whose pattern of keratin expression had already 
been analyzed (Kopan et al.,  1987).  Sections were then subjected to silver 
enhancement (IntenSE; Janssen Life Science Products), according to the 
manufacturer's instructions. Enhancement was stopped at the same time for 
all sections. 
Immunohistochemistry  Followed  by Autoradiography 
Immunohistochemistry was conducted as described above. After stopping 
the  gold  enhancement as  described by  the  manufacturer  Oanssen  Life 
Science Products), slides were dehydrated via a series of 10-min incubations 
in increasing ethanol solutions (from 30 to 100%). After air-drying, slides 
were dipped in NTB2 Kodak emulsion and subjected to autoradiography as 
described above, with the exception that subsequent staining with hema- 
toxylin and eosin after autoradiography was omitted. 
Radiolabeling and Extraction of  Proteins 
Cultures were labeled for 6 h with 30 pCi/ml [3SS]methionine  (specific ac- 
tivity 1,000 Ci/mmol; Amersham Corp.). Extraction of intermediate fila- 
ment proteins was performed using the method previously described by Wu 
et al. (1982).  Rafts were transferred to a Corex centrifuge tube containing 
10 mM Tris-HCl (pH 7.3),  0.6 M  KCI,  1% Triton X-100,  1.7 mM PMSE 
4°C. Cells were lysed with the aid of sonication, and the insoluble fraction 
was pelleted by centrifugation at 15,000 g for 20 min. The pellet was resus- 
pended in the same buffer,  and extracted and centrifuged repeatedly. Inter- 
mediate filament proteins were solubilized by dissolving the washed pellet 
in 8 M  urea, containing 10%  ~-mercaptoethanol. 
lmmunoblot Analyses 
Radiolabeled keratins resolved by SDS-PAGE were transferred to nitrocellu- 
lose by electroblotting. Blots were first stained with Ponceau Red (Sigma 
Chemical Co.) to visualize the transferred proteins. Anti-K6 and anti-K14 
antisera were mixed together in  a  1:1  ratio  and  diluted at  1:200  before 
incubating  with the blot  (Towbin  et al.,  1979).  Bound antibodies were 
visualized by  secondary antibody binding with horseradish peroxidase- 
conjugated goat anti-rabbit IgG (1:2,000  dilution), followed by 4-chloro-1- 
naphthol treatment to develop the color as described by Bio-Rad Laborato- 
Kopan and Fuchs Retinoids, Proliferation, and Epidermal Differentiation  297 Figure 2.  Anti-K6 staining of suprabasal cells of normal and SCC-13 cultures. Epidermal and SCC-13 cells were cultured on rafts at the 
air-liquid interface. Rafts were fixed in Carnoy's solution for 30 min and then embedded in paraffin and sectioned (5 #m). Sections were 
deparattinized and hydrated before exposing them to a  1:100 dilution of a  rabbit polyclonal anti-K6 antiserum in 2%  BSA in PBS.  The 
antibody was visualized using gold-conjugated goat anti-rabbit IgG antibodies, followed by silver enhancement. A, normal epidermal raft; 
B, SCC-13 raft. Note the suprabasal location of anti-K6 staining and the patches of K6-negative cells in the suprabasal layers of SCC-13 
cultures. Note: Carnoy's fixation procedure does not interfere with antibody staining for this or other polyclonal keratin peptide antibodies 
that we have generated (Kopan et ai.,  1987;  Stoler et al.,  1988;  Stoler et al.,  1989).  Bar,  30 #m. 
ries (Richmond, CA).  After photography,  immunoblot analysis  was then 
repeated on the same paper, this time using a general anti-type I keratin an- 
tiserum (Fuchs and Marchuk,  1983),  at  1:50 dilution. 
Isolation of Total RNA 
Total  RNA  was  isolated  from raft cultures according to the method of 
Chomczynski and Sacchi (1987). Rafts were fed 12 h before harvest. Each 
raft was solubilized in 1 ml of [4 M guanidinium thiocyanate,  25 mM so- 
dium citrate,  pH 7.0, 0.5%  Sarkosyl,  0.1 M ~-mercaptoethanol].  To each 
milliliter of cell solution was added, in order, vortexing after each addition: 
0.1 mI 2 M sodium acetate,  1 ml phenol, 0.2 ml chloroform. After 10 addi- 
tional seconds of vortexing, the solution was placed on ice for 15 rain. After 
this incubation, the mixture was subjected to centrifugation at 10,000 g for 
20 rain at 4°C.  The upper aqueous  phase,  containing the RNA, was trans- 
ferred to a clean tube containing an equal volume of isopropanol.  After mix- 
ing, the solution was then placed at -20°C for 1 h, followed by centrifuga- 
tion at 10,000 g for 10 min at 4°C.  The pellet, containing  the RNA, was 
again extracted in 4 M guanidinium hydrochloride solution, and precipitated 
with an equal volume of isopropanol  as described above. The final pellet 
was vortexed in the presence of 75% ethanol at room temperature,  followed 
by brief centrifugation, and finally vacuum drying of the pellet.  The dried 
RNA was then dissolved  in 0.5%  SDS by incubating at 65°C for 10 rain. 
Northern Blot Analysis 
Messenger RNAs were isolated as described above and subjected to North- 
ern blot analyses  as described by Thomas (1980).  32p-dCTP-labeled  sin- 
gle-stranded eDNA probes were prepared from the following plasmids. 
pKS-3'NC, pKA-62  encodes a  K5  human eDNA (Lersch and Fuchs, 
1988). pKS-3'NC  contains the 3' noncoding portion of this K5 eDNA se- 
quence,  and it was prepared by subcloning the Nco  I/Hae II fragment of 
pKA-62,  extending  from 44 nucleotides  to 234 nucleotides  3' of the TAA 
stop codon of the K5 sequence,  into the Sma I site of pGEM2 (Promega 
Biotec, Madison, WI) (Lersch et al.,  1989). Antisense probe was prepared 
by linearizing  pKS-3'NC with Hind III and using a T7 RNA polymerase pro- 
moter primer (Promega Biotec)  and Klenow  fragment in the presence of 
32p-dCTP and unlabeled deoxyribonucleotides. 
K6a-3'NC. pK6a (also referred to as lsp) contains a 1,415-bp Taq I/Sma 
I fragment of pKA-I (Hanukoglu  and Fuchs, 1983; residues 20-1,435),  en- 
compassing the coding portion of K6a,  subcloned into the Hinc II site of 
pSP64, pK6a-YNC  contains a 220-bp Alu I/Spe I fragment extending from 
235 bp 3' past the TAA stop codon of the K6a eDNA to 75 bp 5' from the 
polyadenylation  signal, subcloned in the 3' to 5' direction into the Hinc II 
site of plasmid pGEMI (Promega Biotec).  Antisense probe was prepared 
by linearizing pK6a-YNC  with Hind III and using a T7 promoter primer 
and Klenow fragment as described above. 
Results 
Proliferation  Rates Differ for Normal and SCC-13 
Cultures, but in Both Cases, DNA Synthesis Is Largely 
Restricted to the Basal-like Cells 
To examine the relative proliferative capacities of the normal 
epidermal and squamous cell carcinoma raft cultures, we 
added [3H]thymidine  to the medium under the rafts for 2 h 
before fixation. Cells undergoing DNA synthesis at the time 
of thymidine treatment incorporated the labeled nucleotide, 
and the radiolabeled nuclei could be visualized by autoradi- 
ography of fixed sections of tissue (Fig.  1). Frame A shows 
a section (5 #m) of a normal epidermal raft displaying sev- 
eral radiolabeled nuclei in the basal layer (see the three paral- 
lel arrows in the frame). After examining many additional 
sections, we concluded that while the number of cells incor- 
porating label varied considerably throughout the raft, label- 
ing was largely confined to this layer: Only an occasional 
suprabasal cell showed a radiolabeled nucleus. The mitoti- 
cally active cells  were  also predominantly located in the 
basal layer of the culture. An example of a basal cell fixed 
during the process of mitosis is shown in the inset of frame 
A (thick arrow). 
To test whether the basal epidermal layer might have acted 
as  a  barrier  to  [3H]thymidine,  thereby  leading  to  basal- 
specific radiolabeling of nuclei, we kept an epidermal culture 
submerged under the medium rather than floating it at the 
air-liquid interface. Under submerged conditions, stratifica- 
tion was not only reduced in general, but it was also highly 
variable, with some thicker regions and many poorly strati- 
fied regions (see also Kopan et al.,  1987).  Nevertheless, 
when a submerged culture was labeled with [~H]thymidine, 
it showed basal-preferred incorporation of label, even in the 
thicker regions of the culture (Fig. 1 B). Hence, the restric- 
tion of labeled nuclei to the basal layer of floating cultures 
was not simply due to the fact that these cells were closest 
to the medium containing the label, but rather to an inherent 
proliferative capacity displayed by the basal population of  the 
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[3H]thymidine  studies on human keratinocyte cultures grown 
on plastic (Milstone and LaVigne, 1985; Albers et al., 1987). 
When the squamous cell carcinoma line SCC-13  is cul- 
tured on plastic in the presence of a fibroblast feeder layer, 
it reaches confluence faster than a normal human epidermal 
culture (Rheinwald and Beckett, 1981). To determine whether 
SCC-13 cells also proliferate rapidly when cultured on rafts, 
we repeated our [3H]thymidine experiment using the squa- 
mous cell carcinoma line. While the number of cells incor- 
porating labeled nucleotides varied throughout the raft, sec- 
tions of SCC-13 cultures showed a significantly greater number 
of cells with radiolabeled nuclei than normal (compare nor- 
mal [C] with SCC-13  [D]).  Surprisingly, both the [3H]thy- 
midine incorporation and the location of mitotic cells was 
still predominantly basal, despite the increase in prolifera- 
tive  capacity within  the  culture.  While the percentage of 
suprabasal cells with radiolabeled nuclei or mitotic figures 
was somewhat greater than that observed for normal epider- 
mal raft cultures, DNA synthesis and mitosis in the upper 
layers were still rare events. The increase in cell population 
generated by this increase in cell proliferation seemed to be 
accommodated in three distinct ways:  (a) SCC-13 cultures 
were more stratified than their normal epidermal counterparts, 
(b) basal cells of the SCC-13 cultures were more compact, 
forming several layers of cells,  and  (c) the differentiating 
cells were more crowded than in the normal raft cultures. 
the hyperproliferation-associated keratins and DNA synthe- 
sis may be mutually exclusive in the cultures. To answer this 
question, we took sections (5 #m) of [3H]thymidine-labeled 
SCC-13 cultures and subjected them first to anti-K6 staining 
and  then  to  autoradiography.  Providing that  immunogold 
labeling and silver enhancement was used as an antiserum 
Cells That Stain with Antisera against 
Hyperproliferation-associated Keratins Are Not 
Synthesizing DNA 
Previously, using  an antiserum monospecific for K16,  we 
showed that K16 is present in almost all and only the supra- 
basal  cells of normal  epidermal  raft cultures,  while  it  is 
patchy, but still suprabasally expressed in SCC-13 cultures 
(Stoler et al.,  1988). To determine whether K6, the partner 
hyperproliferation-associated keratin,  is also expressed su- 
prabasally, we used an antiserum monospecific for K6 (Stoler 
et al.,  1989)  and  stained  sections of our cultures.  Fig.  2 
shows  that  similar  to  anti-K16,  anti-K6  stained  only the 
suprabasal, differentiating cells of the normal epidermal cul- 
tures (Fig. 2 A). The staining pattern was consistent through- 
out  the  epidermal  population:  a  single  layer of anti-K6- 
negative basal  cells was overlayed with multiple layers of 
differentiating cells, uniformly staining with the anti-K6 an- 
tiserum.  The lack of staining in basal cells was even more 
apparent in SCC-13 cultures, where the basal-like cells were 
several layers thick (Fig. 2 B). Unlike the normal cultures, 
SCC-13 cultures showed a patchy, suprabasal staining pattern 
with the anti-K6 antiserum.  Interestingly, the same supra- 
basal regions which showed relatively low or nondetectable 
levels of anti-K6  staining  were also  rich with  clusters  of 
basal-like cells. Hence, for both cultures, staining with anti- 
K6 was largely confined to differentiating cells in the supra- 
basal layers. This result is similar to that obtained with tissue 
sections of psoriatic epidermis and squamous cell carcinomas 
(Stoler et al., 1988) and of proliferating epidermis overlying 
dermatofibromas (Stoler et al.,  1989). 
The  fact that  K6/K16 expression was  predominantly in 
differentiating cells and [3H]thymidine labeling and mitotic 
figures were largely in basal cells suggested that expression of 
Figure 3. Coupled use of immunogold enhancement and autoradi- 
ography to examine keratin expression and cell proliferation in raft 
sections. SCC-13 cells were cultured for 10 d on floating rafts before 
[3H]thymidine labeling. After radiolabeling, cultures were fixed, 
embedded in paraffin and sectioned (5 t~m). Sections were hydral~l 
and reacted with one of two antisera: anti-K6, a rabbit polyclonal 
antiserum monospecific for the carboxy terminal sequence of hu- 
man K6 (Stoler et al., 1989), and anti-K14, a rabbit polyclonal an- 
tiserum monospecific for the carboxy terminal sequence of human 
K14 (Stoler et al., 1988). Primary antibodies were visualized with 
gold-conjugated goat anti-rabbit IgG antiserum, followed by silver 
enhancement. After enhancement, sections were dehydrated in eth- 
anol, air-dried,  and subjected to autoradiography as described in 
Materials and Methods. Note: To prevent interference of the two 
procedures, it was important to use this method of antibody staining 
and to conduct  the  staining before autoradiography. A,  anti-K6 
staining/[ZH]thymidine labeling; B, anti-K14  staining/[3H]thymi  - 
dine labeling.. Bar, 30/zm. 
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noid treatments of normal and SCC-13 cultures. Normal 
and SCC-13 cells were cultured for 10 d on floating rafts 
over medium containing retinoic acid at a concentration 
of 0,  1 x  10  -7 M, or 1  x  10  -6 M. 8 h before harvesting 
the rafts, [35S]methionine was added at 30/zCi/ml to the 
culture medium. Keratins were extracted from the epider- 
mal  cells  as  described  previously  (Fuchs  and  Green, 
1980).  Keratins were  resolved by one-dimensional gel 
electrophoresis using SDS polyacrylamide gels (Laemmli, 
1970; gel in A), or two-dimensional gel electrophoresis 
using nonequilibrium  pH gradient gels in the first dimen- 
sion and SDS polyacrylamide gels in the second (O'Far- 
rell et al., 1977; gels in B-D). After electrophoresis, gels 
were fixed in methanol/acetic acid solution and subjected 
to fluorography and autoradiography. Samples in gel in 
A were from: lane 1, normal epidermal culture; lane 2, 
epidermal culture treated with 1 x  10  -6 M retinoic acid; 
lane 3,  SCC-13 culture; lane 4,  SCC-13 culture treated 
with  1  x  10  -7 M  retinoic acid; lane 5, SCC-13 culture 
treated with 1  x  10  -6 M retinoic acid. Samples for two- 
dimensional gels were from: gel in B, SCC-13 cultures; 
gel  in  C,  SCC-13  culture  treated  with  1  ×  10  -7  M 
retinoic acid; gel in D, SCC-13 culture treated with 1  x 
10  -6 M  retinoic acid.  Keratins are identified according 
to the nomenclature of Moll et al. (1982). Thick vertical 
arrow at the top of each two-dimensional gel (B-D) de- 
notes complexes between acidic (type I) and basic (type 
II) keratins which were not resolved in the first dimension 
NEPHGE  gel.  From left to  right,  thin angled arrows 
point to: K6 (56K), K14 (50K), and a 50-K protein that 
is more acidic than K14. 
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autoradiography, the two methods were compatible. Fig.  3 
A revealed that those cells that stained with the anti-K6 an- 
tiserum did not incorporate [3H]thymidine, and those cells 
that incorporated [3H]thymidine did not stain with the anti- 
K6 antiserum. Even when an occasional suprabasal cell was 
synthesizing DNA, the cell did not slain with the anti-K6 an- 
tiserum (arrows, Fig.  3 A). 
Since the  suprabasal  cells that  incorporated  pH]thymi- 
dine were often in clusters of anti-K6-negative regions, and 
since these cells were usually basal-like in their morphology, 
we wondered whether these suprabasal patches also had the 
biochemical characteristics  of basal  cells.  Previously,  we 
showed that the basal layer of normal epidermis stains heav- 
ily with a  monospecific anti-K14 antiserum (Stoler et al., 
1988; Vassar et al.,  1989). To determine whether the anti- 
K6-negative patches  of basal-like  cells  stain  prominently 
with this antiserum, we repeated the staining procedure, this 
time using anti-K14 before autoradiography. Fig. 3 B dem- 
onstrates clearly the presence of both anti-K14 staining and 
[3H]thymidine labeling in a number of basal cells, as well 
as in the suprabasal patches containing basal-like cells. Thus, 
suprabasal  cells  with  [3H]thymidine-labeled  nuclei  were 
consistently found in  patches where anti-K6 staining  was 
weak and anti-K14 staining was strong (arrows, Fig. 3, A and 
B). Collectively, these data suggest that regions containing 
suprabasal cells with activity in DNA synthesis and with lit- 
tle or no anti-K6  staining  may be less differentiated than 
suprabasal areas with stronger anti-K6 staining and no de- 
tectable [3H]thymidine incorporation. 
Inhibition of  K6/K16 Expression  in Retinoic 
Acid-treated SCC-13 Cultures 
Thus far, our studies suggested a reverse correlation between 
anti-K6 staining and DNA synthesis. However, previous in 
vivo studies demonstrated a strong correlation between K6/ 
K16 expression and diseases of epidermal hyperproliferation 
(Weiss et al., 1983,1984; McGuire et al., 1984; Stoler et al., 
1988,1989).  One explanation for this apparent discrepancy 
is that K6/K16 expression may play a role at the tissue level 
rather than the cell level. Thus, for example, expression of 
K6 and K16 in suprabasal layers might be necessary to mani- 
fest or maintain hyperproliferation in the basal layer below. 
To determine whether K6/K16 expression might be necessar- 
ily coupled to epidermal hyperproliferation, we developed 
an in vitro method which would enable us to inhibit K6/K16 
expression and then assess the consequential effects on cell 
proliferation. In the course of our investigation,  we found 
several methods which resulted in a reduction in K6 and K16. 
One of these procedures was to culture SCC-13 cells in the 
absence of fibroblast feeder layers, a process which resulted 
in the development of a population of basal-like cells which 
stratified heavily when cultured at the air-liquid interface, 
but which did not show signs of differentiation or K6/K16 ex- 
pression.  However, this  approach proved to be somewhat 
variable, and it was not well-defined, particularly since the 
biochemical nature of fibroblast-epidermal interactions have 
yet to be elucidated. Hence, we focused our attention towards 
an alternative method for altering differentiation in culture. 
In a previous study, we noted that retinoids, whose inhibitory 
effects on terminal differentiation are well-documented (Fuchs 
and Green, 1981; Eckert and Green, 1984; Kim et al., 1984; 
Kopan et al., 1987), have a slight inhibitory effect  on K6/K16 
expression (Kopan et al., 1987). It was also known that squa- 
mous cell carcinoma cells behave as if they were more sensi- 
tive to retinoids than normal epidermal cells (Kim et al., 
1984). Hence, we investigated the possibility that retinoids 
might significantly reduce K6/K16 expression in SCC-13 raft 
cultures. 
We first compared the keratin patterns produced by normal 
and  SCC-13  cells cultured on rafts over normal medium, 
containing serum retinol, but no added retinoids. Both nor- 
mal and SCC-13 raft cultures expressed K1 (61 kD), K5 (58 
kD), K6 (56 kD), K10 (56.5 kD)., Kll (56 kD), KI4 (50 kD), 
K16 (48 kD), and K17 (46 kD), many of which were resolved 
by one-dimensional gel electrophoresis (Fig. 4 A, compare 
lane I  with 3). While normal and SCC-13 cultures behaved 
similarly in normal medium, their different sensitivities to 
retinoids led to significant differences in keratin patterns when 
retinoic acid was added to the culture medium. While it is 
not very apparent in a one-dimensional gel pattern (Fig. 4 
A,  lane 2),  normal epidermal  rafts required  I  x  10  -6 M 
retinoic acid to yield a near complete suppression of the ter- 
minal differentiation-specific keratins, K1, K10, and K11 (see 
two-dimensional gel data in Kopan et al., 1987). At this high 
concentration, retinoic acid also caused a slight down-regu- 
lation in K6/K16 levels. Even more striking, however, were 
the effects of retinoic acid on the expression of K6, K16, and 
K17 in SCC-13 rafts cultured at the air-liquid interface: at 
1  x  10  -7 M retinoic acid, these keratins were dramatically 
down-regulated (Fig.  4 C), and at 1 ×  10  -6 M retinoic acid, 
these keratins were barely visible (Fig. 4 D). Moreover, the 
K14 spot was markedly reduced, while a new and more acidic 
spot at 50 kD appeared with increasing intensity (right ar- 
row, Fig. 4,  C and D). 
To test whether the more acidic 50-kD spot might be a 
phosphorylated variant of K14,  we  subjected the  radiola- 
beled keratin extract from Fig. 4 C to immunoblot analysis 
(Fig. 5).  Fig. 5 A shows the transferred proteins visualized 
on the blot by Ponceau Red staining. Due to the low sensitiv- 
ity of the staining procedure, only K5, K14, and the acidic 
50-kD spot were visible.  Fig.  5 B shows the blot after in- 
direct immunoreactivity with a mixture of anti-K6 and anti- 
K14, followed by a horse peroxidase-conjugated secondary 
antibody (see Materials and Methods). Under the wash con- 
ditions, the Ponceau Red was removed, and now only anti- 
K6 and anti-K14 cross-reactive spots were visible. These re- 
sults show that the acidic 50-kD spot was not cross-reactive 
with  the  anti-Kl4  antiserum.  To  determine  whether  the 
acidic 50-kD spot was a keratin, the blot was subjected to a 
second round of immunoblot analysis, this time using an an- 
tisera with broader specificity for most type I keratins (Fuchs 
and Marchuk, 1983). In this case, the acidic spot was readily 
detected (C). To verify the efficiency of transfer, the blot was 
subjected to autoradiography (D).  Thus, the 50-kD protein 
was a keratin, and it is still possible that the spot was K14, 
but that a modification in its 15 carboxy terminal amino acid 
residues prevented its  immunoreactivity with the anti-K14 
polyclonal antiserum.  Further studies will be necessary to 
determine whether this keratin is a modified KI4 or another 
keratin, e.g., K15. 
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react with anti-K14. The 135S]methionine-labeled 
keratin extract from SCC-13 rafts cultured in the 
presence of 1 x  10  -7 M retinoic acid was used for 
analysis (see  legend  to  Fig.  4).  Keratins were 
resolved by two-dimensional NEPHGE gel elec- 
trophoresis as indicated in the legend to Fig. 4, and 
unfixed proteins were transferred to nitrocellulose 
by immunoblotting  (Towbin et al., 1979). The blot 
was first stained with Ponceau Red to visualize the 
transferred protein (A). The blot was then exposed 
to anti-K6 and anti-K14, followed by horseradish 
peroxidase-conjugated secondary antibodies and 
developing as described in Materials and Methods 
(B). The blot was then blocked and exposed first 
to a general anti-type I antiserum, followed by a 
horseradish  peroxidase-conjugated secondary an- 
tibody (C). Finally, the blot was exposed to x-ray 
film for 24 h before developing (D).  Keratins are 
identified at left. 
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at the mRNA Level 
Previous in vivo studies have detected K6 mRNA, but not 
protein,  in  normal  human  skin  (Tyner and  Fuchs,  1986; 
Stoler et al., 1988). However, when skin was placed into cul- 
ture medium, the level of K6 mRNAs were elevated by 2-6x 
(Tyner and  Fuchs,  1986).  Hence,  both posttranscriptional 
and transcriptional controls seemed to be operating to regu- 
late K6 expression. To determine whether the retinoid-medi- 
ated suppression of K6 protein expression in vitro is reflected 
at the mRNA level, we isolated total RNA from normal and 
SCC-13 rafts cultured in the presence or absence of retinoic 
acid.  RNAs  (2  #g  each)  were  resolved  by  formaldehyde 
agarose gel electrophoresis and transferred to nitrocellulose 
paper by  blotting  (Thomas  et  al.,  1980).  Duplicate  blots 
were  then  hybridized  with  two  different  32p-radiolabeled 
probes specific for the 3' noncoding portions of K5 and K6a 
mRNAs,  respectively. 
The results of our Northern blot analyses are shown in Fig. 
6. To compare the level of K6 mRNA relative to the level of 
K5 mRNA, each lane hybridized with the K5 probe (left sec- 
tion) was exposed for the same amount of time as the corre- 
sponding lane hybridized with the K6 probe (right section). 
Relative to K5 mRNA, the level of K6 mRNA did not change 
appreciably when normal epidermal rafts were cultured  in 
the presence of retinoic acid (lanes I  and 2, compare left and 
right sections).  In contrast, when the SCC-13 cultures were 
treated with retinoic acid, the level of K6 mRNAs began to 
decline relative to K5 mRNA (lanes 3-5, compare left and 
right  sections).  This  decline  was  evident  at  1  ×  10  -7  M 
retinoic acid (lane 4, right section),  and it was even more 
prominent at  1  ×  10  -6 M  retinoic acid  (lane 5,  right sec- 
tion).  The retinoid-mediated decline in K6 mRNA relative 
to K5 mRNA in SCC-13 cells paralleled the protein data pro- 
vided in Fig. 4, and hence, much of the control in K6 expres- 
sion  seemed  to  be exerted  at  the  mRNA  level.  However, 
when  1  ×  10  -6 M  retinoic acid was present in the culture 
medium, K6 mRNA was still detected, even though the ex- 
pression  of K6  protein  was  almost  completely  inhibited. 
Thus, while most of the regulation in retinoid-mediated re- 
duction  in K6 was at the mRNA level, there seemed to be 
a  low level of post-mRNA control. 
Reduction in K6 and KI6 in Retinoic Acid-treated 
SCC-13 Rafts Is Not Accompanied by a Decrease in 
Cell Proliferation 
A priori, it seemed possible that expression of K6 and K16 
in suprabasal cells and hyperproliferation in basal cells might 
be necessarily linked.  Since retinoic acid completely, sup- 
pressed K6/K16 expression in SCC-13 raft cultures, we won- 
dered whether retinoic acid might also lead to a decrease in 
the proliferation of the basal-like cells. To answer this ques- 
tion, we examined DNA synthesis as a function of increasing 
concentrations  of retinoic  acid  in  a  range from 0  to  1  × 
10  -6 M (Fig. 7). Surprisingly, the number of cells incorpor- 
ating [3H]thymidine showed no decline with increasing con- 
centrations of retinoic acid, and if anything, the percentage 
of incorporating cells increased (Fig. 7, A-C, respectively). 
Stratification of the retinoid-treated cultures decreased, and 
the remaining four to seven layers of cells were basal-like in 
morphology. DNA synthesis often extended into these supra- 
basal layers of retinoid-treated cultures (B and C). The reti- 
noid-mediated inhibition of differentiation also occurred in 
normal epidermal cultures, although it was not as pronounced 
as in the SCC-13 cultures (see Kopan et al., 1987 for retinoid 
studies on normal cultures).  As expected from the protein 
data (Fig. 4), the retinoid-treated SCC-13 cultures showed a 
marked decline in anti-K6 staining (D-F). 
Collectively, our data reveal an uncoupling between K6/K16 
expression and epidermal hyperproliferation: in SCC-13 cells, 
retinoic acid suppressed the processes of both normal (K1/ 
KI0) and abnormal (K6/K16) differentiation without decreas- 
ing proliferation in the basal-like population. 
Discussion 
Epidermal Proliferation and K6/K16 Expression 
A  number of studies  have demonstrated the abnormal ex- 
pression of K6 and K16 in human diseases of the epidermis 
(Baden et al.,  1978; Hunter and Skerrow, 1981; Thaler et al., 
1980;  Breitkreutz et al.,  1981; Weiss et al.,  1983,1984;  Moll 
et al.,  1983,1984;  McGuire et al.,  1984; Leigh et al.,  1985; 
Stoler et al.,  1988,1989).  While these keratins are not nor- 
mally expressed in epidermis,  they are induced transiently 
Figure 6. Northern blot analyses to examine 
the effects of retinoic acid on keratin mRNA 
patterns.  Normal  epidermal  and  SCC-13 
rafts were cultured at the air-liquid interface 
over medium containing 0,  1 x  10  -7, or 1 
×  10  -6 M retinoic acid.  After 10 d, a raft 
from each condition was harvested for RNA 
extraction (Chomcyznski et al.,  1979). To- 
tal RNAs (2 ttg) were loaded in duplicate 
and subjected to electrophoresis  through formaldehyde agarose gels. RNAs were transferred to nitrocellulose by blotting (Thomas et al., 
1980), and one blot was hybridized with radiolabeled eDNA probe to the 3' noncoding portion of K5 mRNA (leJ~), while a duplicate blot 
was hybridized with radiolabeled cDNA probes to the 3' noncoding portions of K6 mRNA (right). Blots were exposed to x-ray film for 
24 h, 3 d,  and 7 d.  Lanes were chosen such that the amount of signal corresponding  to the K5 mRNA band was approximately equal 
for each condition.  For each lane shown in the left blot, the corresponding  lane in the right blot was exposed for exactly the same time. 
Note that the difference in background of lane 4 (K5) and lane 4 (K6) was due to a light leak rather than to different exposure times. Sizes 
were determined  by molecular weight RNA markers and are indicated at the left in kilobase pairs. 
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may be obtained in Materials and Methods.  SCC-13 rafts were cultured at the air-liquid  interface over medium containing 0 (A and D), 
1 x  10  -7 M, (B and E), or 1 x  10  -6 M (C and F) retinoic acid. After 10 d, rafts were labeled with [3H]thymidine for 2 h and then fixed, 
embedded in paraffin, and sectioned (5 #m). Sections were either subjected to autoradiography, followed by hematoxylin, and eosin staining 
(A-C), or subjected to immunohistochemistry  with anti-K6 antiserum (D-F). Bar, 30 #m. 
during wound healing (Lane et al.,  1985;  Mansbridge and 
Knapp,  1987),  or  when  skin is placed into  tissue  culture 
medium in vitro (Sun and Green,  1978;  Fuchs and Green, 
1980;  Tyner and  Fuchs,  1986).  Under all of these condi- 
tions, the expression of K6 and K16 seems to be associated 
with an increase in epidermal proliferation, and it has been 
suggested that the keratin pair may be a biochemical marker 
for hyperproliferating keratinocytes (Weiss et al.,  1984). 
Previously we showed that K6 and K16 are expressed in 
the suprabasal cells of psoriatic epidermis and squamous cell 
carcinoma, concomitantly with a down-regulation of the ter- 
minal differentiation-specific keratins (K1 and K10) (Stoler 
et al., 1988). The shift from the expression of one set of kera- 
tins to another in the suprabasal layers was suggestive that 
the differentiative process was altered in these two diseases 
of epidermal proliferation. However, since epidermal prolif- 
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cells into the suprabasal layers (Lavker and Sun, 1983; Wein- 
stein and Van Scott,  1965;  Leigh et al.,  1985),  it was not 
clear from these early studies whether K6/K16 was expressed 
in mitotically active cells which had undergone an increase 
in number, or whether K6/K16 was expressed in differen- 
tiating, nondividing cells which were derived from a pop- 
ulation of basal ceils which had undergone an increase in 
proliferation. 
Our use of immunohistochemistry coupled with [3H]thy- 
midine labeling left little doubt that the expression of  K6/K16 
and DNA synthesis were mutually exclusive in our in vitro 
cultures. Thus, it seems likely that the abnormal synthesis 
of these keratins in some proliferative diseases also occurs 
predominantly in the differentiating, rather than the dividing, 
cells of the population. Moreover, our discovery that retinoic 
acid inhibits K6  and K16  expression in  SCC-13  raft cul- 
tures and simultaneously gives rise to an increase in the num- 
ber of proliferating (i.e., basal-like) cells within the popula- 
tion argues strongly that the frequent association of these 
keratins with the hyperproliferative state is more likely to be 
a consequence, rather than a cause of increased epidermal 
proliferation. 
While our results demonstrate that K6/K16 do not seem to 
play an essential role in promoting epidermal proliferation, 
this does not necessarily imply that the expression of these 
keratins is irrelevant in contributing to the disease state.  In 
vitro assembly studies have shown that K6 and K16 can each 
coassemble separately with epidermal keratins into 8-nm fil- 
aments (Hatzfeld and Franke, 1985).  In vivo studies involv- 
ing transfection of K6 and K16 genes into tissue culture cells 
have confirmed that each of these keratins incorporates into 
the existing and growing keratin filament network (Giudice 
and Fuchs,  1987; Rosenberg et al.,  •988).  Thus, K6- and 
K16-containing 8-nm filaments probably exist within the ker- 
atin networks of differentiating cells of diseases such as pso- 
riasis or squamous cell carcinomas. It is possible that the 
substitution of K6/Kl6-containing filaments for K1/Kl0-con- 
taining filaments might alter the properties of the cytoskele- 
ton of a cell. Alternatively, such changes could alter the in- 
tercellular interactions within the sheets of suprabasal cells. 
In this regard, recent gene transfection studies have revealed 
that alterations of the cytoskeleton within one cell can influ- 
ence the intercellular interactions and the cytoskeletons within 
adjacent cells (Alhers and Fuchs, •989).  Although intercel- 
lular interactions are known to be affected in scaling diseases 
such as psoriasis, it remains to be tested whether K6/K16 ex- 
pression has a functional role in this or any other feature of 
abnormal differentiation. 
Retinoids and Their Effects on K6/K16 Expression and 
DNA Synthesis: How Might These Effects Be 
Physiologically or Clinically Relevant? 
Since the early studies of vitamin deficiency (Mori,  1922; 
Wolbach  and  Howe,  1925)  and  vitamin excess  (Fell  and 
Melanby, 1953),  vitamin A has been known to have a pro- 
nounced negative affect on epidermal differentiation. Early 
cell culture studies reported morphological changes in ker- 
atinocytes treated with varying amounts of retinoids (Yuspa 
and Harris,  1974; DeLuca and Yuspa,  1974; Sporn et al., 
1975; Elias et al.,  1981). More recently, it was found that 
retinoids at a concentration of*10x higher than physiologi- 
cai can suppress expression of terminal differentiation-spe- 
cific keratins (K1 and K10) (Fuchs and Green, 1981; Kim et 
al., 1984; Eckert and Green, 1984; Gilfix and Green, 1984; 
Kopan et al.,  1987)  as well as proteins involved in cross- 
linked envelope formation (Green and Watt,  1982).  While 
most biochemical studies on the effects of retinoids have been 
conducted with keratinocytes cultured on plastic, it has re- 
cently been demonstrated that retinoids added to the culture 
medium of epidermal cultures floating on rafts of collagen 
and fibroblasts can inhibit the biochemistry and the morphol- 
ogy of the extensive terminal differentiation process which 
takes place in these cultures (Kopan et al.,  1987).  Since in 
vivo, blood vessels supplying vitamin A to skin are located 
in the dermis, it has been suggested that terminal differentia- 
tion both in vitro and in vivo may be programmed by pro- 
gressive migration of differentiating epidermal cells away 
from the source of retinoids (Kopan et al.,  1987). 
A priori, since retinoic acid was known to suppress K1/ 
K10 expression, and since K6/K16 expression was typically 
elevated in epidermal cells when K1/K10 expression was sup- 
pressed, the retinoid might have been expected to enhance, 
rather than suppress K6/K16 expression. The fact that both 
sets of suprabasal keratins are suppressed by retinoic acid 
suggests that the retinoid has a negative effect on both normal 
and abnormal forms of epidermal differentiation. We do not 
yet know why retinoic acid quantitatively inhibited the ex- 
pression of K6/KI6 only in SCC-13 raft cultures, and not in 
normal epidermal raft cultures. However,  previous studies 
by Kim et al. (1984) have shown that when cultured on plas- 
tic, squamous cell carcinoma cells of epidermal origin (Wu 
and Rheinwald, 1981), behaved as if they had an internal reti- 
noid  concentration  ~10x  higher  than  normal  epidermal 
cells. Hence, it may be that the phenomenon depends on the 
degree to which an epidermal cell is sensitive to retinoids. 
If so, at physiological concentrations of retinoids, the sup- 
pression of K6/K16  may only be manifested in epidermal 
cells that have undergone some biochemical change, e.g., 
one similar to that which occurs in malignant transformation 
or psoriasis. 
The suppression of K6/K16 in retinoid-treated cultures of 
SCC-13 but not normal epidermal cells may also be related 
to morphological differences which were observed between 
the two cell cultures: SCC-13 cultures treated with retinoic 
acid appeared undifferentiated, with multiple layers of basal- 
like cells.  This morphology was also observed for feeder- 
independent SCC-13  cultures,  which also  showed inhibi- 
tion of K6/K16 (Kopan, R., D. McCance, L. Laimins, and 
E. Fuchs, unpublished observations). In contrast to SCC-13 
cultures, epidermal cultures treated with retinoic acid re- 
tained a gradient of differentiated cells, similar to that seen 
in vitro for untreated SCC-13 cultures and in vivo for patients 
suffering from hypervitaminosis A  (see also Kopan et al., 
1987). While the basal-like appearance of the retinoid-treated 
or feeder-independent SCC-13 cultures may in part explain 
why they did not show K6/K16 expression, the phenomenon 
is clearly a more complex one: SCC-13 cultures kept sub- 
merged under medium containing up to  1  x  10  -6 M  ret- 
inoic acid also appeared basal-like and yet still expressed K6 
and KI6, as did submerged SCC-13  cultures from feeder- 
independent lines (Kopan, R., and E.  Fuchs, unpublished 
observations).  Thus,  unlike retinoid-mediated suppression 
of K1/KI  0, suppression  of K6/KI  6 in SCC-13 cultures seemed 
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raft at an air-liquid interface. 
In summary,  our studies have demonstrated that low levels 
of retinoids have a profound effect on enhancing the popula- 
tion of basal-like, thymidine-incorporating ceils of both nor- 
mal and squamous cell carcinoma cells cultured on floating 
rafts  at an air-liquid  interface.  Concomitantly,  while reti- 
noids suppress the expression of terminal differentiation-as- 
sociated keratins  in both normal and malignant cells, they 
quantitatively  suppress the expression of the hyperprolifera- 
tion-associated keratins only in the tumor cells, which seem 
to have  ,x,10x  greater  sensitivity  to retinoids than  normal 
keratinocytes.  This  inhibition of K6/K16  seems  to  be  de- 
pendent on the polarity of the culture with respect to its me- 
dia source, and occurs simultaneously with a loss of differen- 
tiated cell morphology. While the functional significance of 
the abnormal expression of K6/K16  remains unknown, the 
process of K6/K16  expression and epidermal  proliferation 
can be uncoupled,  suggesting that these keratins  may  be a 
frequent consequence, rather than a cause, of the hyperpro- 
liferative state. 
Retinoids are commonly used in the clinical treatment  of 
many different skin disorders. Our finding that retinoids can 
inhibit both the expression of K6/KI6 and also the abnormal 
differentiation typically  associated  with hyperproliferation 
might explain some of the therapeutic  effects of vitamin A 
and its analogues on the skin. However, the finding that reti- 
noids can increase the population of basal-like cells without 
a loss in their proliferative potential may be an alarming side 
effect of the successful inhibition of abnormal differentiation. 
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